The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
Construction is now underway with the facility scheduled to be operational by 2025
The observations primarily relate to the need for improving strategies for microbial control, enhancing quality oversight, augmenting the use of software applications & computerized tools
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
The WAVEsystem with the WAVEcontrol 4.0 embedded
Syngene's collaboration with Zoetis started in 2011
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
Both manufacturing facilities are based out of Benguluru, India
Subscribe To Our Newsletter & Stay Updated
